𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The potentiation of arterial contraction with platelet activating factor

✍ Scribed by Mark Kester; Ronald F. Ledvora; Michael Bárány

Publisher
Springer
Year
1984
Tongue
English
Weight
490 KB
Volume
400
Category
Article
ISSN
0031-6768

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Platelet-activating factor interaction w
Platelet-activating factor interaction with the human erythrocyte membrane
✍ Lucyna Mrówczyńska; Henry Hägerstrand 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

## Abstract Platelet‐activating factor (PAF) is a soluble signal messenger present in blood at nanomolar concentration. PAF has a wide spectrum of biological activities and is produced by and effective in different cell types. Owing to its important physiological role, we wanted to characterize mem

Synthesis of azathia analogues of platel
Synthesis of azathia analogues of platelet activating factor with polyheterosidechains
✍ J.M. Zeidler; W. Zimmermann; H.J. Roth 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 417 KB

The synthesis of azathia analogues of the platelet activating factor with oxygen and sulphur-containing sidechains is reported. The starting point is 1-acetylthio-3-hydroxy-2-propaneamine-HCl, which permits the formation of the thioether and the acetamido linkage in one step. The phosphocholine part

Prefertilization treatment of mice with
Prefertilization treatment of mice with platelet activating factor affects pregnancy
✍ B. T. Podsiadly; L. M. Adamson; J. D. Stanger; Y. C. Smart; Dr. T. K. Roberts 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 701 KB

## Abstract Embryo‐derived platelet activating factor (EPAF) is thought to be either biologically similar to platelet activating factor (PAF) or responsible for PAF liberation in vivo. We have previously shown that premating PAF treatment in the mouse renders the platelets nonresponsive to EPAF, le